PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review.

about

PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review.

Item

http://www.wikidata.org/entity/Q55346427

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

PET-CT evaluation of the curat ...... report and literature review.

@en

PET-CT evaluation of the curat ...... report and literature review.

@nl

type

Item

label

PET-CT evaluation of the curat ...... report and literature review.

@en

PET-CT evaluation of the curat ...... report and literature review.

@nl

prefLabel

PET-CT evaluation of the curat ...... report and literature review.

@en

PET-CT evaluation of the curat ...... report and literature review.

@nl

P1476

PET-CT evaluation of the curat ...... report and literature review.

@en

P2093

Dongdong Zhao

http://www.w3.org/2001/XMLSchema#string

Hong Tang

http://www.w3.org/2001/XMLSchema#string

Jiuzhou Zhao

http://www.w3.org/2001/XMLSchema#string

Li Yang

http://www.w3.org/2001/XMLSchema#string

Qiming Wang

http://www.w3.org/2001/XMLSchema#string

Sen Yang

http://www.w3.org/2001/XMLSchema#string

Yufeng Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Chemotherapy and antiangiogenic agents in non-small-cell lung cancer.

Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases.

Advances in combination of antiangiogenic agents targeting VEGF-binding and conventional chemotherapy and radiation for cancer treatment.

Mammary myofibrosarcoma: case report and literature review.

WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.

P304

1921-1927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2147/OTT.S155033

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670367

http://www.w3.org/2001/XMLSchema#string

P921

crizotinib

P932

5896645

http://www.w3.org/2001/XMLSchema#string